Upgrade to SI Premium - Free Trial

UPDATE: PTC Therapeutics (PTCT) Initiated Neutral at UBS

October 27, 2020 4:50 PM
(Updated - October 27, 2020 5:00 PM EDT)

UBS analyst Colin Bristow started PTC Therapeutics (NASDAQ: PTCT) at Neutral, PT $55.00

Categories

New Coverage

Next Articles